| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | AGFG2 TBC1D3I TBC1D3G ARHGAP21 TBC1D3K TBC1D3F TBC1D3E RANBP2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARFGEF1 TBC1D3C TBC1D3B ARHGAP45 | 1.04e-08 | 279 | 189 | 16 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | SIRPB1 AGFG2 TBC1D3I TBC1D3G ARHGAP21 TBC1D3K TBC1D3F RANBP10 TBC1D3E RANBP2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARFGEF1 TBC1D3C TBC1D3B RPGR ARHGAP45 | 3.74e-07 | 507 | 189 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | SIRPB1 AGFG2 TBC1D3I TBC1D3G ARHGAP21 TBC1D3K TBC1D3F RANBP10 TBC1D3E RANBP2 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARFGEF1 TBC1D3C TBC1D3B RPGR ARHGAP45 | 3.74e-07 | 507 | 189 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme regulator activity | WDR81 GCKR SIRPB1 ADGRV1 SSPOP ITIH1 SERPINB11 AGFG2 C4A C4B TBC1D3I TBC1D3G ARHGAP21 TBC1D3K TBC1D3F RANBP10 TBC1D3E RANBP2 TBC1D3 TBC1D3H TBC1D3L FN1 TBC1D3D ARFGEF1 APOC2 TBC1D3C TBC1D3B RPGR ARHGAP45 ATP2B4 HYAL2 | 1.03e-05 | 1418 | 189 | 31 | GO:0030234 |
| GeneOntologyMolecularFunction | enzyme activator activity | AGFG2 TBC1D3I TBC1D3G ARHGAP21 TBC1D3K TBC1D3F TBC1D3E RANBP2 TBC1D3 TBC1D3H TBC1D3L FN1 TBC1D3D ARFGEF1 APOC2 TBC1D3C TBC1D3B ARHGAP45 | 5.41e-05 | 656 | 189 | 18 | GO:0008047 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B ARHGAP45 | 2.96e-10 | 109 | 186 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | ODAM TBC1D3I TBC1D3G TBC1D3K TBC1D3F SEMA4D TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B ARHGAP45 | 4.92e-08 | 244 | 186 | 14 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | ODAM TBC1D3I TBC1D3G TBC1D3K TBC1D3F SEMA4D TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARFGEF1 TBC1D3C TBC1D3B ARHGAP45 | 4.08e-07 | 335 | 186 | 15 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 5.97e-06 | 14 | 186 | 4 | GO:2001046 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | ODAM TBC1D3I TBC1D3G TBC1D3K TBC1D3F SEMA4D TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D GRIN2A APOC2 TBC1D3C TBC1D3B ARHGAP45 | 1.26e-05 | 499 | 186 | 16 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 4.96e-05 | 23 | 186 | 4 | GO:2001044 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.20e-05 | 187 | 186 | 9 | GO:0007156 | |
| HumanPheno | Prominent nasal bridge | HIVEP2 TRRAP GJA8 SCAPER MED12L CPLANE1 MED12 PCDHGC4 KANSL1 SEC24C CTCF CEP41 SPEN UNC80 ATPAF2 | 5.28e-06 | 239 | 83 | 15 | HP:0000426 |
| Domain | TBC | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 4.42e-11 | 49 | 186 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.01e-10 | 53 | 186 | 10 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.49e-10 | 55 | 186 | 10 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.49e-10 | 55 | 186 | 10 | PS50086 |
| Domain | IG_FLMN | 1.91e-06 | 10 | 186 | 4 | SM00557 | |
| Domain | Filamin | 2.98e-06 | 11 | 186 | 4 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.98e-06 | 11 | 186 | 4 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.98e-06 | 11 | 186 | 4 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.98e-06 | 11 | 186 | 4 | IPR017868 | |
| Domain | NHL_repeat_subgr | 7.81e-05 | 9 | 186 | 3 | IPR013017 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.14e-05 | 46 | 186 | 5 | IPR011042 | |
| Domain | Med12 | 9.86e-05 | 2 | 186 | 2 | PF09497 | |
| Domain | Mediator_Med12_catenin-bd | 9.86e-05 | 2 | 186 | 2 | IPR021989 | |
| Domain | Med12-PQL | 9.86e-05 | 2 | 186 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 9.86e-05 | 2 | 186 | 2 | PF12145 | |
| Domain | Med12 | 9.86e-05 | 2 | 186 | 2 | SM01281 | |
| Domain | Mediator_Med12 | 9.86e-05 | 2 | 186 | 2 | IPR019035 | |
| Domain | Mediator_Med12_LCEWAV | 9.86e-05 | 2 | 186 | 2 | IPR021990 | |
| Domain | Cadherin_CS | 1.10e-04 | 109 | 186 | 7 | IPR020894 | |
| Domain | NHL_repeat | 1.11e-04 | 10 | 186 | 3 | IPR001258 | |
| Domain | NHL | 1.11e-04 | 10 | 186 | 3 | PF01436 | |
| Domain | CADHERIN_1 | 1.38e-04 | 113 | 186 | 7 | PS00232 | |
| Domain | Cadherin | 1.38e-04 | 113 | 186 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 1.46e-04 | 114 | 186 | 7 | PS50268 | |
| Domain | - | 1.46e-04 | 114 | 186 | 7 | 2.60.40.60 | |
| Domain | CA | 1.54e-04 | 115 | 186 | 7 | SM00112 | |
| Domain | Cadherin-like | 1.62e-04 | 116 | 186 | 7 | IPR015919 | |
| Domain | Cadherin | 1.80e-04 | 118 | 186 | 7 | IPR002126 | |
| Domain | NHL | 2.58e-04 | 13 | 186 | 3 | PS51125 | |
| Domain | RB_A | 2.94e-04 | 3 | 186 | 2 | IPR002720 | |
| Domain | DUF3452 | 2.94e-04 | 3 | 186 | 2 | PF11934 | |
| Domain | RB_B | 2.94e-04 | 3 | 186 | 2 | IPR002719 | |
| Domain | RB_C | 2.94e-04 | 3 | 186 | 2 | IPR015030 | |
| Domain | RB_fam | 2.94e-04 | 3 | 186 | 2 | IPR028309 | |
| Domain | RB_N | 2.94e-04 | 3 | 186 | 2 | IPR024599 | |
| Domain | RB_A | 2.94e-04 | 3 | 186 | 2 | PF01858 | |
| Domain | RB_B | 2.94e-04 | 3 | 186 | 2 | PF01857 | |
| Domain | DUF3452 | 2.94e-04 | 3 | 186 | 2 | SM01367 | |
| Domain | Rb_C | 2.94e-04 | 3 | 186 | 2 | SM01369 | |
| Domain | RB_A | 2.94e-04 | 3 | 186 | 2 | SM01368 | |
| Domain | LAM_G_DOMAIN | 5.39e-04 | 38 | 186 | 4 | PS50025 | |
| Domain | - | 5.96e-04 | 39 | 186 | 4 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 6.58e-04 | 40 | 186 | 4 | PF02210 | |
| Domain | CONNEXINS_1 | 8.37e-04 | 19 | 186 | 3 | PS00407 | |
| Domain | UBA | 9.47e-04 | 44 | 186 | 4 | IPR015940 | |
| Domain | LamG | 9.47e-04 | 44 | 186 | 4 | SM00282 | |
| Domain | Anaphylatoxin_comp_syst | 9.67e-04 | 5 | 186 | 2 | IPR018081 | |
| Domain | PHR | 9.67e-04 | 5 | 186 | 2 | IPR012983 | |
| Domain | Anaphylatoxn_comp_syst_dom | 9.67e-04 | 5 | 186 | 2 | IPR001840 | |
| Domain | PHR | 9.67e-04 | 5 | 186 | 2 | PF08005 | |
| Domain | Connexin | 9.78e-04 | 20 | 186 | 3 | IPR000500 | |
| Domain | Connexin_CCC | 9.78e-04 | 20 | 186 | 3 | IPR019570 | |
| Domain | Connexin_N | 9.78e-04 | 20 | 186 | 3 | IPR013092 | |
| Domain | Connexin_CCC | 9.78e-04 | 20 | 186 | 3 | SM01089 | |
| Domain | CONNEXINS_2 | 9.78e-04 | 20 | 186 | 3 | PS00408 | |
| Domain | Connexin | 9.78e-04 | 20 | 186 | 3 | PF00029 | |
| Domain | Connexin_CS | 9.78e-04 | 20 | 186 | 3 | IPR017990 | |
| Domain | CNX | 9.78e-04 | 20 | 186 | 3 | SM00037 | |
| Domain | EGF_1 | 1.06e-03 | 255 | 186 | 9 | PS00022 | |
| Domain | UBA | 1.22e-03 | 47 | 186 | 4 | PS50030 | |
| Domain | RIH_assoc-dom | 1.44e-03 | 6 | 186 | 2 | IPR013662 | |
| Domain | SPOC_C | 1.44e-03 | 6 | 186 | 2 | IPR012921 | |
| Domain | Ubiquilin | 1.44e-03 | 6 | 186 | 2 | IPR015496 | |
| Domain | Ins145_P3_rec | 1.44e-03 | 6 | 186 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.44e-03 | 6 | 186 | 2 | PF08454 | |
| Domain | RIH_dom | 1.44e-03 | 6 | 186 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.44e-03 | 6 | 186 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.44e-03 | 6 | 186 | 2 | IPR015925 | |
| Domain | - | 1.44e-03 | 6 | 186 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.44e-03 | 6 | 186 | 2 | PF01365 | |
| Domain | SPOC | 1.44e-03 | 6 | 186 | 2 | PF07744 | |
| Domain | ConA-like_dom | 1.61e-03 | 219 | 186 | 8 | IPR013320 | |
| Domain | ANATO | 2.00e-03 | 7 | 186 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 2.00e-03 | 7 | 186 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.00e-03 | 7 | 186 | 2 | PS01177 | |
| Domain | Cadherin_pro | 2.00e-03 | 7 | 186 | 2 | PF08758 | |
| Domain | ANATO | 2.00e-03 | 7 | 186 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 2.00e-03 | 7 | 186 | 2 | IPR000020 | |
| Domain | - | 2.61e-03 | 95 | 186 | 5 | 2.60.120.200 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.66e-03 | 8 | 186 | 2 | IPR019565 | |
| Domain | Cadherin_pro | 2.66e-03 | 8 | 186 | 2 | SM01055 | |
| Domain | Cadherin_pro_dom | 2.66e-03 | 8 | 186 | 2 | IPR014868 | |
| Domain | Thiol-ester_cl | 2.66e-03 | 8 | 186 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 2.66e-03 | 8 | 186 | 2 | IPR019742 | |
| Domain | Laminin_G | 2.66e-03 | 58 | 186 | 4 | IPR001791 | |
| Domain | EGF_Ca-bd_CS | 2.86e-03 | 97 | 186 | 5 | IPR018097 | |
| Domain | EGF_CA | 3.12e-03 | 99 | 186 | 5 | PS01187 | |
| Domain | RFX_DNA_binding | 3.39e-03 | 9 | 186 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 3.39e-03 | 9 | 186 | 2 | IPR003150 | |
| Domain | RFX_DBD | 3.39e-03 | 9 | 186 | 2 | PS51526 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.18e-03 | 106 | 186 | 5 | IPR000152 | |
| Domain | MIR | 4.21e-03 | 10 | 186 | 2 | PF02815 | |
| Domain | A2M | 4.21e-03 | 10 | 186 | 2 | PF00207 | |
| Domain | STI1 | 4.21e-03 | 10 | 186 | 2 | SM00727 | |
| Domain | MIR_motif | 4.21e-03 | 10 | 186 | 2 | IPR016093 | |
| Domain | A2M_N_2 | 4.21e-03 | 10 | 186 | 2 | IPR011625 | |
| Domain | A2M_comp | 4.21e-03 | 10 | 186 | 2 | IPR011626 | |
| Domain | A2M_recep | 4.21e-03 | 10 | 186 | 2 | PF07677 | |
| Domain | A2M_comp | 4.21e-03 | 10 | 186 | 2 | PF07678 | |
| Domain | A2M_N | 4.21e-03 | 10 | 186 | 2 | PF01835 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3I TBC1D3G TBC1D3K TBC1D3E TBC1D3 TBC1D3H TBC1D3L MED1 TBC1D3C TBC1D3B | 7.39e-08 | 99 | 146 | 10 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B | 1.22e-25 | 11 | 194 | 11 | 16863688 |
| Pubmed | HIVEP2 HSPH1 UBQLN4 BTBD1 MFF GGT7 ITPR3 CACNA1B FLNA DMXL2 UBQLN2 FN1 FANCI SLIT1 | 4.37e-09 | 322 | 194 | 14 | 26514267 | |
| Pubmed | MAML1 MFF RYR2 DHX9 FAT1 ANKRD28 ARHGAP21 FAT4 KRT9 CDC42BPA FN1 YBX1 CCDC186 ARFGEF1 APOB LIG1 SEC24C SYTL4 RPGR SPEN | 1.69e-08 | 777 | 194 | 20 | 35844135 | |
| Pubmed | NES WDR81 SIRPB1 ARMCX4 ITIH1 PRRC2C ANKRD28 ARHGAP21 RANBP10 RANBP2 DMXL2 AAK1 TRIOBP DIDO1 GRIN2A SIK3 TRIM3 SEC24C CTCF DCHS1 ATP2B4 | 1.20e-07 | 963 | 194 | 21 | 28671696 | |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 1.98e-07 | 74 | 194 | 7 | 16625196 | |
| Pubmed | 3.00e-07 | 11 | 194 | 4 | 26114487 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 6.81e-07 | 4 | 194 | 3 | 12359748 | |
| Pubmed | 6.81e-07 | 4 | 194 | 3 | 8406013 | ||
| Pubmed | 6.81e-07 | 4 | 194 | 3 | 26514622 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NES ZNF207 TRRAP DHX9 MED12 ELOC RANBP2 DMXL2 KRT9 SUPT20H CDC42BPA YBX1 TRIOBP DIDO1 TRIM71 SIK3 MED1 SEC24C MORF4L2 SPEN SON | 8.01e-07 | 1082 | 194 | 21 | 38697112 |
| Pubmed | HSPH1 MAML1 ZNF207 TRRAP INO80D PRRC2C CLTB MED12 KNL1 ELOC FLNA RANBP2 EIF4H YBX1 DIDO1 MED1 E2F8 LIG1 RESF1 FANCI SPEN | 1.09e-06 | 1103 | 194 | 21 | 34189442 | |
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 12604796 | ||
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 1988494 | ||
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 8471161 | ||
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 24056717 | ||
| Pubmed | ZNF207 TRRAP PRRC2C ANKRD28 TAF2 ELOC RANBP2 YBX1 TRIM71 LIG1 MORF4L2 FANCI SPEN | 2.66e-06 | 469 | 194 | 13 | 27634302 | |
| Pubmed | 2.70e-06 | 18 | 194 | 4 | 36280666 | ||
| Pubmed | 3.38e-06 | 6 | 194 | 3 | 8132574 | ||
| Pubmed | 3.85e-06 | 162 | 194 | 8 | 15174051 | ||
| Pubmed | HIVEP2 DAB2 C4A CPLANE1 TBC1D3F FLNA RANBP2 SUPT20H CDC42BPA CCDC186 SIK3 USF3 KANSL1 | 3.92e-06 | 486 | 194 | 13 | 20936779 | |
| Pubmed | NES TRRAP ITPR3 PRRC2C ANKRD28 MED12 FLNA RANBP2 FN1 DIDO1 SEC24C CTCF FANCI SPEN SON | 4.48e-06 | 653 | 194 | 15 | 22586326 | |
| Pubmed | MIS18BP1 TRRAP DHX9 TAF2 METTL16 MED12 ELOC EFL1 RANBP2 SUPT20H EIF4H DIDO1 MED1 UFM1 POLR3A BROX CTCF FANCI SON | 4.58e-06 | 1014 | 194 | 19 | 32416067 | |
| Pubmed | SIRPB1 TRRAP INO80D AURKC FAT1 PCDH19 SCAPER ANKRD28 TAF2 KNL1 SUPT20H RNF31 RBL1 SIK3 RESF1 CTCF MORF4L2 ELF3 UNC80 SON | 4.92e-06 | 1116 | 194 | 20 | 31753913 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CT47A1 HSPH1 TRRAP PTPRB ANKRD28 NID1 C4A C4B ARHGAP21 MED12 SUPT20H FN1 SPG11 | 4.99e-06 | 497 | 194 | 13 | 36774506 |
| Pubmed | 5.22e-06 | 21 | 194 | 4 | 21943158 | ||
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 16059920 | ||
| Pubmed | Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. | 6.50e-06 | 47 | 194 | 5 | 14760718 | |
| Pubmed | ZBTB6 UBQLN4 DAB2 RYR2 ANKRD28 NID1 KNL1 FLNA UBQLN2 FN1 ZSCAN4 BTBD2 KANSL1 SON | 6.65e-06 | 591 | 194 | 14 | 15231748 | |
| Pubmed | SLC6A19 ITPR3 TULP4 PTPRM MED12L PLEKHH2 ARHGAP21 AAK1 TRIOBP UFM1 CDH1 | 8.49e-06 | 371 | 194 | 11 | 15747579 | |
| Pubmed | 8.86e-06 | 50 | 194 | 5 | 24449835 | ||
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 9.14e-06 | 24 | 194 | 4 | 26116661 | |
| Pubmed | 1.33e-05 | 92 | 194 | 6 | 37343697 | ||
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 28705793 | ||
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 1.99e-05 | 10 | 194 | 3 | 20976766 | |
| Pubmed | 1.99e-05 | 10 | 194 | 3 | 16884701 | ||
| Pubmed | G1 arrest and differentiation can occur independently of Rb family function. | 1.99e-05 | 10 | 194 | 3 | 21059851 | |
| Pubmed | 1.99e-05 | 10 | 194 | 3 | 18156176 | ||
| Pubmed | 2.00e-05 | 29 | 194 | 4 | 20167577 | ||
| Pubmed | 2.30e-05 | 30 | 194 | 4 | 36732658 | ||
| Pubmed | HSPH1 TULP4 SCAPER PLEKHH2 MED12 PDZRN4 RANBP10 DMXL2 USF3 NPHP3 UNC80 ADAMTSL2 | 2.36e-05 | 493 | 194 | 12 | 15368895 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES MIS18BP1 HSPH1 TRRAP DHX9 ANKRD28 TAF2 MED12 FLNA RANBP2 FN1 DSC1 RNF31 EIF4H YBX1 AAK1 POLR3A KANSL1 SEC24C FANCI SON | 2.45e-05 | 1353 | 194 | 21 | 29467282 |
| Pubmed | BTBD1 MED12L ANKRD28 ARHGAP21 RANBP2 DMXL2 MYOT CDC42BPA FN1 LAMA2 NPHP3 SON | 2.55e-05 | 497 | 194 | 12 | 23414517 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 2.57e-05 | 153 | 194 | 7 | 26365490 | |
| Pubmed | 2.62e-05 | 31 | 194 | 4 | 20031551 | ||
| Pubmed | HSPH1 DAB2 ZXDA FLNA RANBP2 AAK1 DIDO1 MED1 LIG1 FANCI SPEN SON | 2.87e-05 | 503 | 194 | 12 | 16964243 | |
| Pubmed | HSPH1 ZNF207 PRRC2C CLTB C4B ELOC FLNA CDC42BPA FN1 YBX1 AAK1 DIDO1 TRIM71 APOB MED1 UFM1 TRIM3 SEC24C CTCF ATP2B4 SON | 2.97e-05 | 1371 | 194 | 21 | 36244648 | |
| Pubmed | 2.99e-05 | 64 | 194 | 5 | 22261194 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.08e-05 | 351 | 194 | 10 | 38297188 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 25386896 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 19062096 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.10e-05 | 2 | 194 | 2 | 17645767 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 12207352 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 18344446 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.10e-05 | 2 | 194 | 2 | 27758680 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.10e-05 | 2 | 194 | 2 | 3037333 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 11726230 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 4216347 | ||
| Pubmed | Early expression of p107 is associated with 3T3-L1 adipocyte differentiation. | 3.10e-05 | 2 | 194 | 2 | 12242027 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 21849455 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.10e-05 | 2 | 194 | 2 | 8428773 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 3.10e-05 | 2 | 194 | 2 | 21345967 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 2302180 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 22151770 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 29080553 | ||
| Pubmed | Obligatory roles of filamin A in E-cadherin-mediated cell-cell adhesion in epidermal keratinocytes. | 3.10e-05 | 2 | 194 | 2 | 24120284 | |
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 3.10e-05 | 2 | 194 | 2 | 25339671 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 17728371 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 6149580 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 6149581 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 34225581 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 18586264 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 3542363 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 2387317 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 16696970 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 7365238 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 17971360 | ||
| Pubmed | Connexin 50 Regulates Surface Ball-and-Socket Structures and Fiber Cell Organization. | 3.10e-05 | 2 | 194 | 2 | 27281269 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 3.10e-05 | 2 | 194 | 2 | 17971229 | |
| Pubmed | Loss of the mammalian DREAM complex deregulates chondrocyte proliferation. | 3.10e-05 | 2 | 194 | 2 | 24710275 | |
| Pubmed | Connections between connexins, calcium, and cataracts in the lens. | 3.10e-05 | 2 | 194 | 2 | 15452195 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 28234895 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 9860964 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 16537896 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 35898513 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 28873507 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 3794341 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 22785613 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 24768041 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 3.10e-05 | 2 | 194 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 3.10e-05 | 2 | 194 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 3.10e-05 | 2 | 194 | 2 | 7373044 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 3.10e-05 | 2 | 194 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 3.10e-05 | 2 | 194 | 2 | 16098595 | |
| Pubmed | Defining a link between gap junction communication, proteolysis, and cataract formation. | 3.10e-05 | 2 | 194 | 2 | 11395508 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 3.10e-05 | 2 | 194 | 2 | 15787745 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 30026462 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 6559257 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 12480675 | ||
| Interaction | MTNR1B interactions | 5.48e-06 | 135 | 190 | 9 | int:MTNR1B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3I TBC1D3G TBC1D3K TBC1D3F TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D MED1 TBC1D3C TBC1D3B | 2.20e-12 | 149 | 194 | 12 | chr17q12 |
| Cytoband | 17q12 | 4.26e-06 | 99 | 194 | 6 | 17q12 | |
| GeneFamily | Cadherin related | 2.04e-04 | 17 | 125 | 3 | 24 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.92e-04 | 21 | 125 | 3 | 813 | |
| GeneFamily | Gap junction proteins | 4.51e-04 | 22 | 125 | 3 | 314 | |
| GeneFamily | Ubiquilin family | 4.68e-04 | 5 | 125 | 2 | 783 | |
| GeneFamily | Regulatory factor X family | 1.29e-03 | 8 | 125 | 2 | 1153 | |
| GeneFamily | Cyclins|Mediator complex | 1.51e-03 | 33 | 125 | 3 | 1061 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.65e-03 | 9 | 125 | 2 | 1234 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 HIVEP2 TRRAP FAT1 PTPRM PRRC2C ANKRD28 MN1 RANBP2 DMXL2 TRIM2 SUPT20H CDC42BPA ARFGEF1 SPG11 SIK3 MED1 CTCF RPGR SPEN ATP2B4 SON | 2.99e-07 | 856 | 190 | 22 | M4500 |
| Coexpression | GSE45837_WT_VS_GFI1_KO_PDC_UP | 1.34e-05 | 195 | 190 | 9 | M9892 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L TBC1D3D TRIM71 TBC1D3C TBC1D3B | 8.40e-09 | 90 | 191 | 10 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L FN1 TBC1D3D TBC1D3C TBC1D3B DCHS1 CDH1 | 9.66e-06 | 281 | 191 | 12 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L FN1 TBC1D3D TBC1D3C TBC1D3B DCHS1 CDH1 | 9.66e-06 | 281 | 191 | 12 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L FN1 TBC1D3D TBC1D3C TBC1D3B | 2.42e-05 | 213 | 191 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3G TBC1D3K TBC1D3F TBC1D3 TBC1D3H TBC1D3L FN1 TBC1D3D TBC1D3C TBC1D3B | 2.42e-05 | 213 | 191 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Myeloid Cells, MF.Lu, CD11chi CD11b- CD103- MHCII- SiglecF+, Lung, avg-3 | 1.04e-04 | 83 | 191 | 6 | GSM538282_100 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-07 | 184 | 193 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-07 | 184 | 193 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-07 | 184 | 193 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-07 | 160 | 193 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-07 | 160 | 193 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-07 | 168 | 193 | 8 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 188 | 193 | 8 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.33e-06 | 196 | 193 | 8 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.51e-06 | 198 | 193 | 8 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-06 | 158 | 193 | 7 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-06 | 160 | 193 | 7 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 162 | 193 | 7 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 162 | 193 | 7 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.26e-06 | 163 | 193 | 7 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 164 | 193 | 7 | 15d52666e5150e7c34b1f641a937fb2d5e8aaf8a | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.55e-06 | 164 | 193 | 7 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 164 | 193 | 7 | d622f0d8d8bad48dfdf160ec63c545df192637a9 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.67e-06 | 108 | 193 | 6 | ee924deacd14ea404fda80ed633960143fd474c0 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.84e-06 | 168 | 193 | 7 | c0aef5947b1d7e2c81a7481c509feda1687fcd7f | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.84e-06 | 168 | 193 | 7 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.84e-06 | 168 | 193 | 7 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.84e-06 | 168 | 193 | 7 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.19e-06 | 169 | 193 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 169 | 193 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.92e-06 | 171 | 193 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 172 | 193 | 7 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 175 | 193 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 176 | 193 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-05 | 176 | 193 | 7 | d30241fb8119834d6e7b59efec3f92fc7a3d1247 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-05 | 177 | 193 | 7 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 180 | 193 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.49e-05 | 182 | 193 | 7 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 1.49e-05 | 182 | 193 | 7 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 185 | 193 | 7 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.83e-05 | 188 | 193 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-05 | 189 | 193 | 7 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.96e-05 | 190 | 193 | 7 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.96e-05 | 190 | 193 | 7 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.03e-05 | 191 | 193 | 7 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.03e-05 | 191 | 193 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.17e-05 | 193 | 193 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-05 | 194 | 193 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 194 | 193 | 7 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.24e-05 | 194 | 193 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.32e-05 | 195 | 193 | 7 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-05 | 196 | 193 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 197 | 193 | 7 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-05 | 197 | 193 | 7 | e77c91f5a1f5a292eda41abf3b1e31180f2c61e1 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 2.56e-05 | 198 | 193 | 7 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-05 | 198 | 193 | 7 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-05 | 198 | 193 | 7 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.56e-05 | 198 | 193 | 7 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-05 | 198 | 193 | 7 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 199 | 193 | 7 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-05 | 199 | 193 | 7 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.64e-05 | 199 | 193 | 7 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.64e-05 | 199 | 193 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.64e-05 | 199 | 193 | 7 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.64e-05 | 199 | 193 | 7 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.73e-05 | 200 | 193 | 7 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.73e-05 | 200 | 193 | 7 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.73e-05 | 200 | 193 | 7 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 2.73e-05 | 200 | 193 | 7 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 5.32e-05 | 152 | 193 | 6 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-05 | 154 | 193 | 6 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 156 | 193 | 6 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.36e-05 | 157 | 193 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 157 | 193 | 6 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 157 | 193 | 6 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 157 | 193 | 6 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | facs-Liver|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 158 | 193 | 6 | ea7db6bd9742153ceb6e444892a6d1df9c7fcc96 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 158 | 193 | 6 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 158 | 193 | 6 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-05 | 159 | 193 | 6 | c0e55f25271f788c08fa4b95186501fc27b2ec39 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 160 | 193 | 6 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-05 | 160 | 193 | 6 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 161 | 193 | 6 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 165 | 193 | 6 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-05 | 166 | 193 | 6 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.66e-05 | 166 | 193 | 6 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-05 | 167 | 193 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.25e-05 | 168 | 193 | 6 | 00cff4698db14e03ca1d1b409e5ed1ad23b12615 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 169 | 193 | 6 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.55e-05 | 169 | 193 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 169 | 193 | 6 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.55e-05 | 169 | 193 | 6 | b059304543876f514d5c7214f1f0a2da00f10a67 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-05 | 169 | 193 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.55e-05 | 169 | 193 | 6 | 90c00ab30e582b0e2a2be751e1fae9024cfb9ea6 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-non-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.55e-05 | 169 | 193 | 6 | 945f737984c4de70a4e9c214053b005358053dd5 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 56 | 193 | 4 | af55596513ddbe60b08648b27e41a7b65e3da58c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 172 | 193 | 6 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 172 | 193 | 6 | 36fe66a8c0aecee7a19269be23210c0ed7abb155 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 173 | 193 | 6 | 9b957dd442f3af0e5fb99f3c93606308a459d485 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 173 | 193 | 6 | a0e4d25db186b9f7ff819abc0db68ad58c92ba3b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 173 | 193 | 6 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 173 | 193 | 6 | 1ea8b8b89611bebf6acb700fb04a7d38720775a9 | |
| Drug | myristicin | 8.53e-07 | 10 | 185 | 4 | CID000004276 | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 2.53e-05 | 189 | 185 | 9 | 6649_DN | |
| Drug | ethosuximide | 3.11e-05 | 74 | 185 | 6 | CID000003291 | |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; PC3; HT_HG-U133A | 3.11e-05 | 194 | 185 | 9 | 4194_UP | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 3.51e-05 | 197 | 185 | 9 | 6217_DN | |
| Drug | NO-1886 | 3.51e-05 | 46 | 185 | 5 | CID000131601 | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A | 3.65e-05 | 198 | 185 | 9 | 5672_UP | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | 3.65e-05 | 198 | 185 | 9 | 5053_UP | |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 3.80e-05 | 199 | 185 | 9 | 4140_DN | |
| Drug | NSC2801 | 3.90e-05 | 47 | 185 | 5 | CID000000471 | |
| Drug | Natamycin [7681-93-8]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.95e-05 | 200 | 185 | 9 | 7167_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; HL60; HT_HG-U133A | 3.95e-05 | 200 | 185 | 9 | 2558_UP | |
| Drug | Sulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A | CYP3A5 LAX1 SCAPER CDC42BPA DSPP AAK1 ZC2HC1C GRIN2A SLC44A1 | 3.95e-05 | 200 | 185 | 9 | 2814_UP |
| Drug | teucrin A | 4.28e-05 | 9 | 185 | 3 | CID000159529 | |
| Drug | PD138142-15 | 4.28e-05 | 9 | 185 | 3 | CID003025787 | |
| Drug | geldanamycin | CYP1A1 NES MIS18BP1 DHX9 PRRC2C METTL16 KNL1 FN1 CCDC186 RFX7 RESF1 CDH1 | 5.48e-05 | 371 | 185 | 12 | ctd:C001277 |
| Drug | XeC compound | 6.38e-05 | 84 | 185 | 6 | CID000005701 | |
| Drug | oxarbazole | 6.57e-05 | 2 | 185 | 2 | CID000037184 | |
| Drug | FOE 3440 A | 6.57e-05 | 2 | 185 | 2 | CID000160310 | |
| Drug | 2,2',3,4,4',6-hexachlorobiphenyl | 6.57e-05 | 2 | 185 | 2 | CID000063080 | |
| Drug | hexahydroindole | 6.57e-05 | 2 | 185 | 2 | CID000579465 | |
| Drug | 2-ethyl-2-phenylsuccinimide | 6.57e-05 | 2 | 185 | 2 | CID003014207 | |
| Drug | 1,2-diphenylethyl isothiocyanate | 6.57e-05 | 2 | 185 | 2 | CID000150153 | |
| Drug | N-3-fluorenylacetamide | 6.57e-05 | 2 | 185 | 2 | CID000022722 | |
| Drug | nafimidone alcohol | 6.57e-05 | 2 | 185 | 2 | CID000130368 | |
| Drug | 3,7-DAU | 6.57e-05 | 2 | 185 | 2 | CID000092287 | |
| Drug | N-hydroxy-3-fluorenylacetamide | 6.57e-05 | 2 | 185 | 2 | CID000031071 | |
| Drug | 2,2-diphenylethyl isothiocyanate | 6.57e-05 | 2 | 185 | 2 | CID000154904 | |
| Drug | ostruthin | 6.57e-05 | 2 | 185 | 2 | CID005281420 | |
| Drug | AC1L1VKI | 6.57e-05 | 2 | 185 | 2 | CID000036327 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.22e-05 | 50 | 176 | 5 | EFO_0022334 | |
| Disease | Colorectal Carcinoma | ZNF155 CSMD3 MFF FAT1 ODAM NID1 PDZRN4 MYOT FN1 ARFGEF1 APOB GRIN2A LIG1 DCHS1 CDH1 | 2.22e-05 | 702 | 176 | 15 | C0009402 |
| Disease | gamma-glutamylthreonine measurement | 2.43e-05 | 10 | 176 | 3 | EFO_0021143 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 2.43e-05 | 10 | 176 | 3 | OBA_2045163 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 3.32e-05 | 11 | 176 | 3 | OBA_2045170 | |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 3.54e-05 | 2 | 176 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 3.54e-05 | 2 | 176 | 2 | cv:C1832390 | |
| Disease | hypobetalipoproteinemia (is_marker_for) | 3.54e-05 | 2 | 176 | 2 | DOID:1390 (is_marker_for) | |
| Disease | Periventricular gray matter heterotopia | 3.54e-05 | 2 | 176 | 2 | C1849173 | |
| Disease | Disorder of eye | 4.31e-05 | 212 | 176 | 8 | C0015397 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 6.93e-05 | 37 | 176 | 4 | EFO_0022252 | |
| Disease | intellectual disability (implicated_via_orthology) | 8.78e-05 | 75 | 176 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | triacylglycerol 52:3 measurement | 9.00e-05 | 15 | 176 | 3 | EFO_0010415 | |
| Disease | Hypertriglyceridemia | 9.00e-05 | 15 | 176 | 3 | C0020557 | |
| Disease | diabetes mellitus (is_marker_for) | 1.04e-04 | 41 | 176 | 4 | DOID:9351 (is_marker_for) | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 1.06e-04 | 3 | 176 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | FG syndrome (is_implicated_in) | 1.06e-04 | 3 | 176 | 2 | DOID:14711 (is_implicated_in) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 1.06e-04 | 3 | 176 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 1.06e-04 | 3 | 176 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | FG SYNDROME 4 (disorder) | 1.06e-04 | 3 | 176 | 2 | C1845546 | |
| Disease | FG SYNDROME 2 | 1.06e-04 | 3 | 176 | 2 | C1845902 | |
| Disease | FG SYNDROME 3 | 1.06e-04 | 3 | 176 | 2 | C1845567 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.06e-04 | 3 | 176 | 2 | C1842563 | |
| Disease | FG syndrome | 1.06e-04 | 3 | 176 | 2 | C0220769 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.15e-04 | 42 | 176 | 4 | EFO_0022255 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.26e-04 | 43 | 176 | 4 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.26e-04 | 43 | 176 | 4 | EFO_0022290 | |
| Disease | choline measurement | 1.34e-04 | 130 | 176 | 6 | EFO_0010116 | |
| Disease | Salivary Gland Neoplasms | 1.79e-04 | 47 | 176 | 4 | C0036095 | |
| Disease | FG syndrome | 2.11e-04 | 4 | 176 | 2 | cv:C0220769 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.27e-04 | 50 | 176 | 4 | EFO_0022303 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 2.46e-04 | 51 | 176 | 4 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.46e-04 | 51 | 176 | 4 | EFO_0022331 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.46e-04 | 51 | 176 | 4 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 2.46e-04 | 51 | 176 | 4 | EFO_0022240 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.56e-04 | 21 | 176 | 3 | DOID:9884 (implicated_via_orthology) | |
| Disease | resting heart rate | 2.81e-04 | 149 | 176 | 6 | EFO_0004351 | |
| Disease | triglycerides in HDL measurement | 2.85e-04 | 53 | 176 | 4 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.85e-04 | 53 | 176 | 4 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 2.85e-04 | 53 | 176 | 4 | EFO_0022258 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.98e-04 | 355 | 176 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | total lipids in medium VLDL | 3.07e-04 | 54 | 176 | 4 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 3.07e-04 | 54 | 176 | 4 | EFO_0022321 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 3.07e-04 | 54 | 176 | 4 | EFO_0022244 | |
| Disease | hearing impairment | 3.09e-04 | 98 | 176 | 5 | C1384666 | |
| Disease | urate measurement | CYP1A1 UBQLN4 GCKR ADGRV1 GJA9 GJA8 ALDH16A1 SCAPER ANKRD28 NID1 PDZRN4 DSPP AAK1 TEX14 TIGD2 | 3.25e-04 | 895 | 176 | 15 | EFO_0004531 |
| Disease | triglycerides in medium VLDL measurement | 3.29e-04 | 55 | 176 | 4 | EFO_0022155 | |
| Disease | triglycerides in very large HDL measurement | 3.29e-04 | 55 | 176 | 4 | EFO_0022324 | |
| Disease | cholesterol to total lipids in large HDL percentage | 3.29e-04 | 55 | 176 | 4 | EFO_0022234 | |
| Disease | phospholipids in medium HDL measurement | 3.29e-04 | 55 | 176 | 4 | EFO_0022295 | |
| Disease | Morbilliform Drug Reaction | 3.38e-04 | 23 | 176 | 3 | C0406537 | |
| Disease | Drug Eruptions | 3.38e-04 | 23 | 176 | 3 | C0011609 | |
| Disease | Malignant Cystosarcoma Phyllodes | 3.50e-04 | 5 | 176 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 3.50e-04 | 5 | 176 | 2 | C0010701 | |
| Disease | triglycerides in very large VLDL measurement | 3.53e-04 | 56 | 176 | 4 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.53e-04 | 56 | 176 | 4 | EFO_0022333 | |
| Disease | cholesterol to total lipids in large LDL percentage | 3.53e-04 | 56 | 176 | 4 | EFO_0022235 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 3.53e-04 | 56 | 176 | 4 | EFO_0022251 | |
| Disease | triglycerides in IDL measurement | 4.04e-04 | 58 | 176 | 4 | EFO_0022149 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 4.04e-04 | 58 | 176 | 4 | EFO_0022338 | |
| Disease | total lipids in medium HDL measurement | 4.04e-04 | 58 | 176 | 4 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 4.04e-04 | 58 | 176 | 4 | EFO_0022267 | |
| Disease | triglycerides in VLDL measurement | 4.31e-04 | 59 | 176 | 4 | EFO_0022326 | |
| Disease | cholesterol in medium HDL measurement | 4.31e-04 | 59 | 176 | 4 | EFO_0021903 | |
| Disease | phospholipids in VLDL measurement | 4.31e-04 | 59 | 176 | 4 | EFO_0022301 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 4.31e-04 | 59 | 176 | 4 | EFO_0022260 | |
| Disease | triglycerides to total lipids in large HDL percentage | 4.60e-04 | 60 | 176 | 4 | EFO_0022330 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 4.60e-04 | 60 | 176 | 4 | EFO_0021898 | |
| Disease | total lipids in VLDL measurement | 4.60e-04 | 60 | 176 | 4 | EFO_0022314 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 4.60e-04 | 60 | 176 | 4 | EFO_0022237 | |
| Disease | triglycerides in small VLDL measurement | 4.90e-04 | 61 | 176 | 4 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 4.90e-04 | 61 | 176 | 4 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 4.90e-04 | 61 | 176 | 4 | EFO_0022276 | |
| Disease | phospholipids in HDL measurement | 4.90e-04 | 61 | 176 | 4 | EFO_0022293 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.90e-04 | 61 | 176 | 4 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | triglycerides in small HDL measurement | 5.21e-04 | 62 | 176 | 4 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 5.21e-04 | 62 | 176 | 4 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 5.21e-04 | 62 | 176 | 4 | EFO_0022339 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 5.21e-04 | 62 | 176 | 4 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 5.21e-04 | 62 | 176 | 4 | EFO_0022313 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 5.21e-04 | 62 | 176 | 4 | EFO_0022263 | |
| Disease | phospholipids in very large VLDL measurement | 5.21e-04 | 62 | 176 | 4 | EFO_0022299 | |
| Disease | hydrocephalus (is_implicated_in) | 5.22e-04 | 6 | 176 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | Abnormal corpus callosum morphology | 5.22e-04 | 6 | 176 | 2 | C1842581 | |
| Disease | Ciliopathies | 5.27e-04 | 110 | 176 | 5 | C4277690 | |
| Disease | total lipids in HDL measurement | 5.54e-04 | 63 | 176 | 4 | EFO_0022307 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 5.54e-04 | 63 | 176 | 4 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 5.54e-04 | 63 | 176 | 4 | EFO_0022292 | |
| Disease | cholesterol in large VLDL measurement | 6.24e-04 | 65 | 176 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 6.24e-04 | 65 | 176 | 4 | EFO_0022230 | |
| Disease | total lipids in small VLDL | 7.00e-04 | 67 | 176 | 4 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 7.00e-04 | 67 | 176 | 4 | EFO_0022175 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 7.25e-04 | 118 | 176 | 5 | EFO_0010119 | |
| Disease | Achromatopsia | 7.28e-04 | 7 | 176 | 2 | C0152200 | |
| Disease | triglycerides in very small VLDL measurement | 7.40e-04 | 68 | 176 | 4 | EFO_0022144 | |
| Disease | triglycerides to phosphoglycerides ratio | 7.40e-04 | 68 | 176 | 4 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 7.40e-04 | 68 | 176 | 4 | EFO_0022265 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 7.52e-04 | 30 | 176 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 7.82e-04 | 69 | 176 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | renal cell carcinoma (is_implicated_in) | 7.82e-04 | 69 | 176 | 4 | DOID:4450 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDNSVSSNPNGINGE | 81 | Q9BXT4 | |
| GSENSEQIANFPSGN | 86 | Q7Z3E2 | |
| AGEELATANQTAQQP | 16 | Q9UQB9 | |
| NQEIFQEVVGGFPSQ | 321 | P11597 | |
| LGFEVQGTQQPQQDE | 16 | P02655 | |
| NSPQIGQFSGNTALE | 2346 | Q7Z407 | |
| PQNQTDGGEVVQDVN | 41 | P49711 | |
| PEVQDIQQNTDGSGQ | 416 | P0C0L5 | |
| QSQGAQVFQAGDVPS | 361 | Q8IZ83 | |
| AIAQFPVVSQGGSQQ | 511 | Q2M2I8 | |
| GTSFGVNIDSLNNPQ | 186 | P20815 | |
| GCFQGPQTDEGVQLQ | 136 | Q9Y6D6 | |
| QGDQEAPVSQEGAQA | 11 | P0C2W7 | |
| SQVNPNSEQGEQVYD | 196 | Q7Z2Z2 | |
| AGNEAQNSGERNITP | 71 | P0C5Y9 | |
| AGNEAQNSGERNITP | 71 | P0C5Z0 | |
| SGNENGAFSINPQTG | 3446 | Q6V0I7 | |
| TIQEFGDPNGVVQFA | 4631 | Q8WXG9 | |
| GEQSPSPEQFINNAG | 116 | Q9BYV8 | |
| EPQNAVDIQDGNGQT | 641 | O15084 | |
| EDGPQVAGSNNSTDN | 181 | Q9NZW4 | |
| QGSPFAQELLDDGQQ | 161 | P78545 | |
| GQQLTTNGAQTFGPD | 441 | Q8N283 | |
| PNVLVGTAFNVDDGN | 371 | Q8TDJ6 | |
| FGGQFNFQDETPTTN | 631 | Q00975 | |
| GSAQPQAVANSQGEV | 826 | Q5H9R4 | |
| DGEVTPYANTNNNAV | 1206 | P23634 | |
| LQTPGEIVDANFGQQ | 206 | Q6VN20 | |
| LENGTGFQAQDISGQ | 1916 | P49792 | |
| GRPNQNNQEGTSTEG | 241 | Q6ZMN7 | |
| NNNFGEVVGSGNPAD | 221 | P04798 | |
| FFVSDVPNNGQNVLD | 481 | Q14573 | |
| ANENGGITFFPVQVN | 751 | Q08999 | |
| QVPQDSLGQALAGQA | 46 | Q96T59 | |
| NASDPDEGTNGQVVY | 261 | Q8TAB3 | |
| QGDQEAPVSQEGAQA | 11 | Q5JQC4 | |
| ETSATNGQPDQQAAP | 6 | P98082 | |
| GDPLGQFAVETIQNE | 2961 | Q14517 | |
| VTGNDEKAFEVNPQG | 3481 | Q14517 | |
| GQQGDSNNNLSPFSI | 296 | Q9NVI1 | |
| LPTNSGQQDRGVAQF | 731 | Q92585 | |
| GQQDRGVAQFPGSQN | 736 | Q92585 | |
| GTQVLQVQAQAPDGG | 1016 | Q96JQ0 | |
| QYEANEQGNGRTIPE | 806 | P23467 | |
| YSQAANGTEGQPQAI | 346 | Q12913 | |
| NGTEGQPQAIEFRTN | 351 | Q12913 | |
| DVQASPNEGFVNQNI | 61 | Q12891 | |
| VGNLPFNTVQGDIDA | 46 | Q15056 | |
| QEPGSGQVFVTSENQ | 151 | Q86YD5 | |
| DGPAQQLSGFNTNQS | 1091 | Q92619 | |
| PDGNLFGAEVSDQQN | 531 | Q2Q1W2 | |
| VKQGFNNQPAFTGDE | 41 | Q86YW9 | |
| RFPDDQVNNTIQNGG | 561 | Q6P0N0 | |
| GQNDVFDFTQPAGVS | 231 | Q96JG8 | |
| QNVSITQGEGGFEIN | 51 | Q8N5M1 | |
| DLEQGFQEGVPNASV | 61 | Q9GZY8 | |
| VQDPNTGFSVNGQLI | 701 | P19827 | |
| GQNSGDVNVEINVAP | 301 | P35527 | |
| FSPQDNTQVCVTGNG | 161 | Q96MR6 | |
| AGVEEANQGFPAVQL | 2421 | Q2LD37 | |
| SEAGTQPQVQTDAQQ | 536 | Q92598 | |
| SQQDGAAGVPETNAA | 1316 | Q5SYE7 | |
| FGDPQIFQQGAVVTD | 131 | Q9UJ14 | |
| ENNQVPAVVAFSQGS | 211 | P14543 | |
| TNFENQPGQGSDASN | 131 | Q8IXT1 | |
| EASFAQGAQAGQVDP | 96 | A1E959 | |
| EGLQDPEGQSQQVGA | 1036 | P48681 | |
| PGSAENNGNANILIA | 31 | Q7Z3B3 | |
| NVPAADPSGSQQQAE | 296 | Q8IWV1 | |
| GAQDQEASEQFGSPV | 486 | Q86W50 | |
| QGSQPRGQQSAEEEN | 6 | Q15014 | |
| GPSQGQETNEVCEQA | 396 | Q86TH1 | |
| LPATGNFSEIENQTQ | 356 | Q8NG31 | |
| ESQQQQVGGFEGPEQ | 141 | Q8N3J3 | |
| VKQGFNNQPAVSGDE | 41 | Q93074 | |
| VDGNQVEAQSPNPAS | 3041 | P24043 | |
| PIVQINGNAAQFGEV | 411 | Q9UK32 | |
| QAQGQAPINNTGFAF | 396 | Q9P0K8 | |
| PEESQEGTFVGNVAQ | 36 | Q9Y5F7 | |
| FPSQNGHDGSTDVQQ | 91 | E9PIF3 | |
| NTPAFSLVEDTNGNQ | 151 | Q96PC2 | |
| VAAGSNNVNVGSEFE | 916 | Q8IVE3 | |
| EGIPQAQQAETGNSF | 51 | Q9Y5Q6 | |
| AELTNQGPQFTFSQE | 376 | Q14397 | |
| AQPFEITASTNNEGN | 3041 | P04114 | |
| APQQFSEDGDFVINN | 1201 | Q8N6C5 | |
| EAGTQVNEGFQPLVE | 171 | P22748 | |
| ESVNVAPENAGTQQG | 766 | A0AVK6 | |
| VGQENLTPQQDSSVF | 2321 | Q9H799 | |
| AIQAFGNGTDVNVSP | 351 | O00451 | |
| NDEQSGFICNTEQPG | 46 | P57773 | |
| NPAEFVVNTSNAGAG | 2446 | P21333 | |
| VGNSVNEGLNQPTDD | 2281 | P02751 | |
| GENEVFNQETFPEGT | 226 | Q6ZPD8 | |
| SPGNNNGTSIEDGQI | 461 | Q9H0C5 | |
| GDEQSDFVCNTQQPG | 46 | P48165 | |
| VDQGLSLSQEPQGNA | 166 | Q96BT3 | |
| NEVTGAPAQFEGTEQ | 1861 | Q9BTC0 | |
| LSGPGQFAENETNEV | 46 | Q15369 | |
| VAVISSNQFGPGLNQ | 316 | P42701 | |
| ASQPETEGGGNSQQE | 241 | A4D2B0 | |
| QGNENGNFIISTDPN | 396 | Q08554 | |
| QIQGQFSAPANVGLT | 751 | Q53TQ3 | |
| TTGSPVQNEQGFVEF | 361 | Q8WWI5 | |
| EGSNPEGIQSQVQEN | 1026 | Q9NRM1 | |
| GDEQSDFTCNTQQPG | 46 | Q9Y6H8 | |
| GNNNGTSVEDGQIPE | 506 | Q9BX70 | |
| SQIQNQQGEDSGSDP | 901 | P18858 | |
| FGQGDVQNGPSSTVQ | 86 | P53992 | |
| ERQSNGEGIGVFQQS | 276 | Q8N697 | |
| TFIQDLAQTPGQAEN | 1346 | Q9BY12 | |
| DSEGNFNPQPVDTSN | 2696 | Q92736 | |
| LESSQSQGQDQPGVE | 81 | A6NLW8 | |
| SQGQDQPGVEFQSRE | 86 | A6NLW8 | |
| SVAFPAENGVQNTES | 111 | P20382 | |
| LNDDGGQFVVTTNPV | 416 | P12830 | |
| GQFVVTTNPVNNDGI | 421 | P12830 | |
| PEVQDIQQNTDGSGQ | 416 | P0C0L4 | |
| TQVFTNTGPDNNLDV | 976 | Q08211 | |
| NPDLLNSQSQSGFGE | 866 | Q15648 | |
| TSPNQGFNLNGIVEI | 561 | Q3ZCN5 | |
| QLNANSINGDGPIVA | 301 | P28827 | |
| NQGIAPSGEIENQAV | 46 | Q7Z2X7 | |
| QFEPQVNSRNAGQGE | 6 | Q10571 | |
| SESQQGIADGFQQPE | 721 | Q92834 | |
| TQPGGQNVVFVDEGE | 241 | Q96C24 | |
| NGFDLPEGNVTQENF | 346 | Q695T7 | |
| PGKQNTDEQFQCTQG | 836 | Q8IWB6 | |
| FTQNQQDDFLTPAGD | 701 | A2VEC9 | |
| QAQGIQVFDPGESDS | 201 | Q7Z494 | |
| VIFPNNFETGNGGNV | 591 | P28749 | |
| NPNENVSTIGNFTNL | 326 | Q9HCM1 | |
| PESVAGNQEAANNPS | 1011 | Q6P1X5 | |
| VNVDAETFPGTQGQK | 176 | Q96D09 | |
| TDTIQFGAPASNGNE | 2051 | Q9Y520 | |
| QQAISGSRVPDGFEN | 801 | O14802 | |
| FQAPVNIQAEQAGTA | 406 | Q9Y2K2 | |
| FNGAPTANFQQDVGT | 211 | P15907 | |
| ETLVEPGSFSQQNGE | 791 | Q92854 | |
| ETSPNAFLNQAVAGG | 461 | Q6P1J6 | |
| EFGVEFSQINQPDSN | 86 | Q96P15 | |
| SPNGGTVQGLQDQQE | 226 | B9A6J9 | |
| EQFILDGPAQTNGQC | 11 | Q5VT25 | |
| AGAFQAQDEGRSQQP | 1321 | Q9H2D6 | |
| NGNELSDFQTNVDPA | 186 | Q5TFQ8 | |
| LQGQVPSAQQDAVFE | 96 | Q5VW32 | |
| APSNGQLNFTDQGVE | 251 | Q14246 | |
| TPLVQQQNGSSFGDL | 426 | O95081 | |
| TVNGDVFQEANGPAD | 71 | P09497 | |
| NAQANVGSQEPADRG | 116 | Q16281 | |
| NNPVFRSTVDAVQGG | 101 | Q96EP0 | |
| NGNELSDFQTNVDPA | 186 | O00241 | |
| SPGGVSQVVQNEENE | 1091 | Q96JI7 | |
| SPNGGTVQGLQDQQE | 226 | A6NDS4 | |
| SPNGGTVQGLQDQQE | 226 | P0C7X1 | |
| ENLQPEQIYGADQTG | 166 | Q4W5G0 | |
| TPDDQQVLFGTADGQ | 176 | Q9NRJ4 | |
| SAFIHQVENQGSPGQ | 146 | Q8N2C7 | |
| NEGSESAPEGQAQQR | 171 | P67809 | |
| VPESNQAQGESPAAN | 2356 | Q96T58 | |
| SPNGGTVQGLQDQQE | 226 | A6NER0 | |
| IQSADGQQVQIGFTG | 176 | Q02447 | |
| CGQNTENQVNPATFG | 51 | Q6ZV50 | |
| PGEQGSEQGSTSQEQ | 661 | Q8NEM7 | |
| TDTPGFGDQINNDNC | 111 | Q8IYM1 | |
| VIENGSPNNSLNNVF | 676 | Q8IZM8 | |
| TGQAEATPNEFNSQG | 1186 | Q68DE3 | |
| QESSFNGEVNGVPQE | 526 | O15040 | |
| SPNGGTVQGLQDQQE | 226 | A0A087X179 | |
| TGQINFSPGDNQAQS | 1226 | Q2KHR2 | |
| FSPGDNQAQSEIGEQ | 1231 | Q2KHR2 | |
| VAEQLFGPQAQAENT | 301 | P12271 | |
| TNGQPQALLVDGDQS | 81 | Q16473 | |
| GNLISQTLNGSEFQP | 526 | Q9NYK1 | |
| NITAQLQEGEGNCFP | 51 | P49190 | |
| TNDGIGINPAQTAGN | 51 | P61960 | |
| ENSAFQQSQGPAVQR | 21 | Q8NAM6 | |
| ISQQDPESDSQGQGN | 91 | Q53FD0 | |
| QAQAAVQGPVGTDFK | 291 | O43670 | |
| QEGETQFGFPNAAGN | 766 | P98168 | |
| NSQFFENGDVPSQVE | 121 | Q12901 | |
| GVGFQTQPNNEVSAK | 286 | Q9BXG8 | |
| SPNGGTVQGLQDQQE | 226 | A0A087WVF3 | |
| NAAQEQFGGNPFASV | 281 | Q9UHD9 | |
| NGQFNAPTGVAVDSN | 666 | Q9C040 | |
| EPEQIGNTASAQLFG | 51 | P31629 | |
| SNNQIAEIAPDAFQG | 341 | O75093 | |
| QSPDQINGESFQNVS | 1916 | Q5T5U3 | |
| SPNGGTVQGLQDQQE | 226 | Q6DHY5 | |
| SPNGGTVQGLQDQQE | 226 | Q8IZP1 | |
| GSGNSQVQTPEVRFQ | 546 | Q9NRR5 | |
| CQVNDNTNTAGSPGE | 2106 | Q9Y4A5 | |
| GQLNGETNTPIEGNQ | 31 | P18583 | |
| SPNGGTVQGLQDQQE | 226 | A0A087X1G2 | |
| GEGQLPQVVFSDGQQ | 1451 | Q562E7 | |
| SPNGGTVQGLQDQQE | 226 | A0A087WXS9 | |
| SPNGGTVQGLQDQQE | 226 | Q6IPX1 | |
| NGQFNAPTGVAVDSN | 666 | O75382 | |
| EVPGNQDQGLFCENT | 266 | Q15916 | |
| PLNEVFQVSQEGAGN | 226 | Q13508 | |
| GPQNAAAVFQAQDDS | 191 | Q9UBF9 | |
| ETGNPATGEQVYQQD | 1256 | Q12879 |